Home › Proteostasis Therapeutics Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics For Novel Therapies Targeting Most Common CF Mutation
 

Keywords :   


Proteostasis Therapeutics Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics For Novel Therapies Targeting Most Common CF Mutation

2014-03-05 04:23:36| drugdiscoveryonline News Articles

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, recently announced an extension of its funded collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT)

Tags: common foundation extension collaboration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
More »